Shengfeng Li

Title: Innovations of Shengfeng Li in Immunotherapy

Introduction

Shengfeng Li is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of immunotherapy, particularly in the development of novel treatments for cancer. With a focus on innovative solutions, he has secured a total of 3 patents that highlight his expertise and dedication to advancing medical science.

Latest Patents

Among his latest patents is the invention titled "ANTIBODY BINDING TO PD-1." This patent focuses on the development of an anti-TIGIT immunosuppressant and its applications. The immunosuppressant is designed to bind to the extracellular region of human TIGIT, providing a potential therapeutic option for treating various diseases, including cancer.

Career Highlights

Shengfeng Li is currently employed at Bio-Thera Solutions, Ltd., where he continues to work on groundbreaking research and development projects. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing the impact of his work.

Collaborations

Some of his notable coworkers include Junjie Huang and Xiaoyun Wu. Their collective efforts contribute to the innovative environment at Bio-Thera Solutions, Ltd., fostering advancements in immunotherapy.

Conclusion

Shengfeng Li's contributions to immunotherapy through his patents and work at Bio-Thera Solutions, Ltd. demonstrate his commitment to improving cancer treatment options. His innovative spirit and collaboration with other experts in the field continue to pave the way for future advancements in medical science.